Sign In
Last checked at 
14 Jul 2011 07:00
14 July 2011
ValiRx Plc (AIM: VAL)
("ValiRx" or the "Company")
Directors' Shareholdings
The Company announces that on 13 July 2011 the following Directors purchased ordinary shares of 0.1 pence each in the Company ("Ordinary Shares") at a purchase price of 0.63p per share.
Name of Director | Number of shares purchased | Total number of shares held Subsequent to the purchase
| Percentage of issued share capital |
|
Satu Vainikka | 1,235,555 | 17,879,776 | 1.71% |
|
George Morris | 538,770 | 11,948,714 | 1.14% |
|
Gerry Desler | 538,770 | 6,693,531 | 0.64% |
|
Kevin Alexander | 538,770 | *3,977,520 | 0.38% |
|
*In the Company's announcement released on 11 July 2011, Kevin Alexander's total shareholding was incorrectly reported as being 2,688,750. At the time of the announcement his total shareholding was in fact 3,438,750.
The issued share capital of the Company comprises 1,044,562,609 Ordinary Shares of 0.1 pence each.
For more information please contact:
ValiRx plc Dr Satu Vainikka | www.Valirx.com Tel: +44 (0) 20 3008 4416 |
Cairn Financial Advisers LLP Nominated Adviser Liam Murray/Avi Robinson |
Tel: +44 (0) 20 7148 7900 |
Hybridan LLP Broker Claire Noyce |
Tel: +44 (0) 20 7947 4350 |
Peckwater PR Tarquin Edwards | Tel: +44 (0) 7879 458 364 tarquin.edwards@peckwaterpr.co.uk |
Follow the stocks
